StonvexLoading…
StonvexStonvexStonvexCore line items from MDIA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $133.34M | $95.57M | $32.39M | $38.59M |
Operating Income | $-24.76M | $-28.21M | $-6.79M | $-1.39M |
Net Income | $-66.22M | $-1.30M | $-7.63M | $30.91M |
EPS (Diluted) | $-0.84 | $-0.08 | $-0.40 | $2.06 |
Total Assets | $291.06M | $325.50M | $95.49M | $96.70M |
Total Liabilities | $244.74M | $242.98M | $29.33M | $23.39M |
Cash & Equivalents | $5.11M | $4.44M | $3.82M | $10.93M |
Free Cash Flow OCF − CapEx | $1.20M | $-20.98M | $-6.38M | $2.12M |
Shares Outstanding | 79.39M | 59.82M | 24.88M | 13.38M |